,,ii #aaeth ,,congress #ast ,session ,s4 #aebh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,july #aa1 #bjag,ms4 ,murkowski 7for herself1 ,mr4 ,sullivan1 ,ms4 ,cantwell1 and ,mr4 ,merkley7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to amend the market name of genetically altered salmon in the ,united ,states1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,genetically ,engineered ,salmon ,labeling ,act4 #b4 ,purposes ,it is the purpose of this ,act to-- 7#a7 ensure that consumers in the ,united ,states can make informed decisions when purchasing salmon2 and 7#b7 authorize an independent scientific and technical advisory organization to conduct a review of-- 7,a7 the possible effects of genetically engineered salmon on wild salmon stocks2 and 7,b7 the ,food and ,drug ,administration's approval of genetically engineered salmon for human consumption4 #c4 ,market name for genetically engineered salmon 7a7 ,in ,general ,notwithstanding any other provision of law1 for purposes of applying the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq471 the acceptable market name of any salmon that is genetically engineered shall include the words 8,genetically ,engineered0 or ,,ge prior to the existing acceptable market name4 7b7 ,definition ,for purposes of this section1 salmon is genetically engineered if it has been modified by recombinant ,,dna 7r,d,n,a7 techniques1 including the entire lineage of salmon that contain the r,d,n,a modification4 #d4 ,third-party review of certain salmon approval 7a7 ,independent scientific organization review and report ,the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary7 shall ensure that the ,national ,academy of ,sciences1 or a similar independent scientific and technical advisory organization1 conducts a review of1 and submits to the ,secretary a report on-- 7#a7 the environmental assessment carried out by the ,food and ,drug ,administration and released on ,november #ab1 #bjae1 in support of approval of the new animal drug application under section #eab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;b7 with respect to ,aqu,advantage ,salmon1 taking into account the impact of ,aqu,advantage ,salmon on wild stocks of salmon and related wild ecosystems2 and 7#b7 each environmental assessment carried out by the ,food and ,drug ,administration in support of an approval of a new animal drug application under section #eab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;b7 related to a genetically engineered finfish intended for human consumption4 7b7 ,second ,,fda environmental assessment ,after receipt of a report under paragraph 7#a7 or 7#b7 of subsection 7a71 the ,secretary shall conduct a second environmental assessment with respect to approval of the application described in such paragraph 7#a7 or 7#b71 taking into account the findings in such report4 7c7 ,effective date of approval ,notwithstanding any other provision of law1 the approval of a new animal drug application with respect to which review of an environmental assessment is required under subsection 7a7 shall not take effect until the ,secretary completes a second environmental assessment under subsection 7b74